NICOLE NIELSEN: Open Payments
NPI 1831862309 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 84 payments from 19 companies in 2025. Trend: 2023 $15 · 2024 $912 · 2025 $2,118
Food & beverage: $2,118
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $430 |
| AstraZeneca Pharmaceuticals LP | 14 | $311 |
| Regeneron Healthcare Solutions, Inc. | 5 | $176 |
| Novartis Pharmaceuticals Corporation | 8 | $162 |
| Grifols USA, LLC | 6 | $151 |
| GlaxoSmithKline, LLC. | 2 | $142 |
| CSL Behring | 6 | $137 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $115 |
| Regeneron Pharmaceuticals, Inc. | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
Products named: DUPIXENT, NUCALA, Prolastin-C Liquid, TEZSPIRE, Hizentra, NEFFY, FASENRA, AIRSUPRA.
Industry payments across UT — which companies pay providers there.
